How should an Open University course on 'Reducing the Risk of Cancer' best present its subject matter? It might do well to base itself on The Causes of Cancer by Doll and Peto. This course, seemingly intended mainly for those in health education, unfortunately does badly. The 'individual study pack' consists of two readers (200 pages each), two audio cassettes, an activity booklet (50 hours of activities) and a workbook. The course dispenses not only with Doll and Peto's book but with the analytical approach that the book fosters, and adopts what seems to be an increasing trend in contemporary education, sacrificing factual material for opinion, controversy and discussion. We listen, for example, to a 15-min consultation between 'Adam Forman', a general practitioner, and 'Pam', a professional women (who lacks a surname!), on Pam's eating habits ('make notes as you listen'). We do not ask whether the advice would reduce the risk of cancer, but we consider what techniques Adam uses to persuade Pam, the main features of his plan and how Pam is helped by Adam. Next we hear Adam and Pam talking separately about the useful points of the consultation, and finally we 'turn to our workbooks for feedback on this activity'.
Even if we accept such one-to-one consultations with healthy individuals as a realistic basis for preventing cancers it is difficult to envisage the facile approach of the course producing useful results. With such a large amount of material on the prevention of cancer the dearth of factual matter is alarming. There is scarcely more than a page on mammographic screening for breast cancer, no account of the trials, no estimate of the percentage reduction in breast cancer mortality that is likely to result from the National Screening Programme in Britain. With its inclination to activity and discussion rather than reading and study the course might encourage an informed discussion among its students on whether the reduction in breast cancer mortality justifies the costs of screening, and introduce formal means of addressing the issue. But the activities are superficial.
Much of the interest in the subject of preventing cancer is lost with the dilution of factual material. There is little on the wide variation in incidence of many cancers around the world, little on the genetics of cancer, little on theories of exponential cancer growth or how an apparently early detection of cancer may represent just one doubling time of a cancer that has experienced 30. Smoking gets more space, but the approach remains superficial and judgement gives way, even here, to a perceived need to present both sides of an argument; thus a 'case for tobacco' is presented, which includes the statement that 'the tobacco industry is philanthropic and generous'. There is a guide to monthly testicular self-examipation, graphically illustrated but without discussion on the lack of evidence that it would reduce mortality. Consensus conferences are espoused rather than guidelines on how an individual might assess evidence. should proceed no further! The book is divided into 11 chapters covering the major haematopoietic disease groups -AML, MDS, ALL (adults only), CGL, CLL, myeloma, HCL, Hodgkin's and NHL and then two final chapters on supportive care and the management of infectious complications. All the chapters are written by acknowledged authorities in their field, and this is reflected in the wealth of experience recorded here that makes it very much a practising clinicians' book.
There are some imbalances. ALL -never a favourite M.D. Anderson disease and the only chapter written by someone from out of town -takes up only 16 pages of text, whereas CGL takes up 70. The discussion of BMT in AML might be regarded by the connoisseur as reflecting traditional M.D. Anderson differences of opinion in this field, and to my mind underplays the role of BMT in AML. However, those of us who know and love the institution can forgive these little peccadillos, as a vast amount of useful information is presented throughout the book in a clear fashion. I particularly liked the use in some chapters of treatment guidelines for subgroups of disease and for certain regimens, for example when to use interferon as opposed to deoxycoformycin in HCL.
The most difficult area to discuss and present clearly is always NHL because of the heterogeneity of the disease. Fernando Cabanillas, however, has written an excellent account, although the mixture of Rappaport and Working Formulation short-hand terms may be confusing at first sight to UK and other European colleagues. I was surprised not to read more about the platinum/Ara-C combinations (another M.D. Anderson 'discovery') in this chapter, but was less surprised to see no mention of allografting at all! Supportive care has also made an important impact, particularly during high-dose intensification; indeed, the original IBM cell separators were developed in conjunction with the M.D. Anderson team. Short sections within the chapter discuss blood product support, the management of tumour lysis, mucosistis and the emerging role of growth factors. Infections are dealt with in an unusual way -by disease group and then again by site of infection, with a final section on prophylaxis.
The whole book is heavily referenced and has a good number of diagrams and illustrations to complement the text. I can agree with the editors that it represents the current 'state of the art' for treatment, though for how long remains to be seen. In conclusion, despite its price, I would strongly
